8-K: Nutra Pharma Corp. Reports Change in Control

Nutra Pharma Corp. announced a change in control on August 21, 2026, with Pure Raw Supplies, LLC acquiring controlling voting power through a gift of Series B Preferred Stock.

Summary

• Nutra Pharma Corp. reported a change in control of the company on August 21, 2026.
• Rik Deitsch transferred 12,000,000 shares of Series B Preferred Stock to Pure Raw Supplies, LLC as a gift.
• These Series B Preferred Stock shares carry supermajority voting rights.
• As a result of this transfer, Pure Raw Supplies, LLC now holds 62.63% of the company's total voting power.
• Pure Raw Supplies, LLC has become the controlling stockholder of Nutra Pharma Corp.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to a significant change in control without disclosed consideration, raising questions about the transaction's fairness and future strategic direction.

Negatives

• A change in control occurred via a gift of stock, with no consideration paid, which may raise questions about the transaction's valuation and terms.
• The transfer of significant voting power to a new controlling stockholder could lead to shifts in company strategy and management.

Risks

• The new controlling stockholder, Pure Raw Supplies, LLC, may implement strategies that do not align with the interests of all shareholders.
• The lack of consideration in the stock transfer could indicate underlying issues or future financial pressures.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing regarding future operations or financial performance.

Management Comments

• "As a result of the transfer of the Series B Preferred Stock, a change in control of the Company occurred on August 21, 2026, and Pure Raw Supplies, LLC became the controlling stockholder of the Company."
• "Immediately following the transfer, Pure Raw Supplies, LLC, through ownership of the Series B Preferred Stock, possessed 62.63% of the total voting power of the Companys outstanding capital stock."
• "Prior to the transfer, such voting power was held by Rik Deitsch."
• "No consideration was paid in connection with the transfer."

Industry Context

StockSavvy.ai notes that changes in control, especially those involving significant voting power shifts through preferred stock, are critical events that can signal strategic realignments or potential operational changes within the biotechnology and pharmaceutical sectors.

Corporate Governance

Related Party Transactions

• Transfer of 12,000,000 shares of Series B Preferred Stock from Rik Deitsch to Pure Raw Supplies, LLC as a gift.

Stakeholder Impact

• Shareholders: Potential shift in company strategy and management priorities under new controlling ownership.
• Creditors: May be impacted by changes in financial strategy or operational focus.
• Employees: Could face changes in management, company direction, or operational structure.

Next Steps

• Monitor the strategic direction and operational changes under the new controlling stockholder, Pure Raw Supplies, LLC.
• Observe any future disclosures regarding the business plans of Pure Raw Supplies, LLC concerning Nutra Pharma Corp.

Key Dates

Recommendation

The change in control is a significant event, but without further information on the new controlling stockholder's plans or the underlying reasons for the gift of stock, it is prudent to hold and await further developments rather than making a decisive buy or sell recommendation.

Keywords

Change in Control, Voting Power, Preferred Stock, Stockholder, Corporate Governance, Securities Transfer